Data Entry: Please note that the research database will be replaced by UNIverse by the end of October 2023. Please enter your data into the system https://universe-intern.unibas.ch. Thanks

Login for users with Unibas email account...

Login for registered users without Unibas email account...

 
Hydrogen sulfide attenuates calcification of vascular smooth muscle cells via KEAP1/NRF2/NQO1 activation
JournalArticle (Originalarbeit in einer wissenschaftlichen Zeitschrift)
 
ID 4050592
Author(s) Aghagolzadeh, Parisa; Radpour, Ramin; Bachtler, Matthias; van Goor, Harry; Smith, Edward R.; Lister, Adam; Odermatt, Alex; Feelisch, Martin; Pasch, Andreas
Author(s) at UniBasel Odermatt, Alex
Lister, Adam
Year 2017
Title Hydrogen sulfide attenuates calcification of vascular smooth muscle cells via KEAP1/NRF2/NQO1 activation
Journal Atherosclerosis
Volume 265
Pages / Article-Number 78-86
Mesh terms Calcium, metabolism; Cells, Cultured; Cytokines, metabolism; Dose-Response Relationship, Drug; Enzyme Activation; Gene Expression Profiling, methods; High-Throughput Nucleotide Sequencing; Humans; Hydrogen Sulfide, metabolism; Kelch-Like ECH-Associated Protein 1, metabolism; Muscle, Smooth, Vascular, pathology; Myocytes, Smooth Muscle, pathology; NAD(P)H Dehydrogenase (Quinone), metabolism; NF-E2-Related Factor 2, metabolism; Oxidative Stress, drug effects; RNA Interference; Signal Transduction, drug effects; Sulfides, pharmacology; Transfection; Vascular Calcification, prevention & control
Abstract Vascular calcification is a common health problem related to oxidative stress, inflammation, and circulating calciprotein particles (CPP). Hydrogen sulfide is an endogenous signaling molecule with antioxidant properties and potential for drug development targeting redox signaling. Yet, its molecular mechanisms of action in vascular smooth muscle cell (VSMC) calcification have not been delineated. We therefore sought to identify key pathways involved in the calcification-inhibitory properties of sulfide employing our recently developed CPP-induced VSMC calcification model.; Using next-generation sequencing, we investigated the transcriptomic changes of sodium hydrosulfide-treated versus non-treated calcifying VSMCs. The potential role of candidate genes and/or regulatory pathways in prevention of calcification was investigated by small interfering RNA (siRNA).; CPP led to a pronounced accumulation of cell-associated calcium, which was decreased by sulfide in a concentration-dependent manner. Both, CPP-induced hydrogen peroxide production and enhanced pro-inflammatory/oxidative stress-related gene expression signatures were attenuated by sulfide-treatment. Gene ontology enrichment and in silico pathway analysis of our transcriptome data suggested NAD(P)H dehydrogenase [quinone] 1 (NQO1) as potential mediator. Corroborating these findings, silencing of Kelch-like ECH-associated protein 1 (KEAP1), an inhibitor of nuclear factor (erythroid-derived 2)-like 2 (NRF2) nuclear activity, enhanced NQO1 expression, whereas NRF2 silencing reduced the expression of NQO1 and abrogated the calcification-suppressing activity of sulfide. Moreover, immunofluorescence microscopy and Western blot analysis confirmed nuclear translocation of NRF2 by sulfide in VSMC.; Sulfide attenuates CPP-induced VSMC calcification in vitro via the KEAP1-NRF2 redox sensing/stress response system by enhancing NQO1 expression.
ISSN/ISBN 1879-1484
edoc-URL https://edoc.unibas.ch/62789/
Full Text on edoc No
Digital Object Identifier DOI 10.1016/j.atherosclerosis.2017.08.012
PubMed ID http://www.ncbi.nlm.nih.gov/pubmed/28865326
Document type (ISI) Journal Article
 
   

MCSS v5.8 PRO. 0.375 sec, queries - 0.000 sec ©Universität Basel  |  Impressum   |    
03/05/2024